Cellaviva AB is a Swedish AB based in Huddinge, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2024, the company reported revenue of 7,1 mn kr in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Biobank för familjesparande av stamceller och därmed förenlig verksamhet.
In its most recent annual report (2025), Cellaviva AB reported revenue of 7,1 mn kr. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net profit of 7,5 mn kr, and the EBITDA margin stood at -105.4%.
At the end of 2025, equity financed 1% of the balance sheet, and current assets covered short-term debt 1.4 times.
Frequently asked questions
What is the Org number of Cellaviva AB?
Cellaviva AB is registered with Bolagsverket / SCB under Org 5594820564.
What is the revenue of Cellaviva AB?
Cellaviva AB reported revenue of 7,1 mn kr in 2025.
Who is the CEO of Cellaviva AB?
Anna Sofie Falk Jansson is the CEO of Cellaviva AB.
Who is the chairman of Cellaviva AB?
Mathias Gösta Svahn chairs the board of Cellaviva AB.
Where is Cellaviva AB headquartered?
Cellaviva AB's registered address is Hälsovägen 7.
